This article was originally published in The Rose Sheet
Consumer products first half revenues dropped 16% "due largely to shifting of customer delivery schedules" that have an impact on when revenues are recorded, the company reported Sept. 4. IGI expects "to see an acceleration of orders from customers who needed to reduce their first half inventories" in the consumer division and an "evening out" of revenues by year's end. The firm's Novasome microencapsulation technology was incorporated in two Connie Stevens Forever Spring skin care products during the first half of the year. IGI also started receiving revenues from Johnson & Johnson's Roc and ph5.5 Novasome products during the same period. Overall, IGI net sales in the first half declined 12% to $15.7 mil. and 17.1% to $7.6 mil. in the second quarter. The company reported a net loss of $1.6 mil. through six months...
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review